CONTROLLED SUBSTANCE-PRESCRIBE House SponsorsRep. Deb Conroy-Jay Hoffman, Anna Moeller, Kelly M. Cassidy, Katie Stuart and Thomas M. Bennett 1/10/2023HouseSession Sine Die 720 ILCS 570/322 new Amends the Illinois Controlled Substances Act. Provides that a prescriber shall offer a prescription for naloxone hydrochloride, or another similar drug approved by the Food and Drug Administration, under specified circumstances. Provides for educational information to be provided concerning overdose prevention and the use of naloxone hydrochloride. Provides that a prescriber who does not comply with specified requirements shall be subject to administrative sanctions under the appropriate licensing board. Specifies that the provisions do not create a private right of action against a prescriber, and do not limit a prescriber's liability for the negligent failure to diagnose or treat a patient. Provides that these provisions do apply to a patient receiving hospice care in accordance with the Hospice Program Licensing Act. Contains a purpose provision. Effective immediately. 1/28/2021HouseFiled with the Clerk by Rep. Deb Conroy 1/29/2021HouseFirst Reading 1/29/2021HouseReferred to Rules Committee 2/17/2021HouseAdded Chief Co-Sponsor Rep. Jay Hoffman 3/2/2021HouseAssigned to Health Care Licenses Committee 3/9/2021HouseRe-assigned to Mental Health & Addiction Committee 3/9/2021HouseAdded Co-Sponsor Rep. Anna Moeller 3/9/2021HouseAdded Co-Sponsor Rep. Kelly M. Cassidy 3/10/2021HouseAdded Co-Sponsor Rep. Katie Stuart 3/16/2021HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Deb Conroy 3/16/2021HouseHouse Committee Amendment No. 1 Referred to Rules Committee 3/18/2021HouseHouse Committee Amendment No. 1 Rules Refers to Mental Health & Addiction Committee 3/26/2021HouseAdded Co-Sponsor Rep. Thomas M. Bennett 3/27/2021HouseRule 19(a) / Re-referred to Rules Committee 3/27/2021HouseHouse Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee 1/10/2023HouseSession Sine Die